Skip to content
MedsAcross

Brand family

Jideytro

Zidesamtinib · Nuvalent
United States
Presentations
2
Markets
1

Jideytro is a brand of Zidesamtinib marketed by Nuvalent, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Zidesamtinib
Brand owner
Nuvalent
Registered in
United States
Strengths and forms
100 mg tablet, 25 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Jideytro 100 mg tabletOralNuvalentUS FDAAvailable on request
Jideytro 25 mg tabletOralNuvalentUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Jideytro

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.